6533b86ffe1ef96bd12cdf7d
RESEARCH PRODUCT
Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines
Serdar OzkokAnne Sophie BoureauRoman PfisterGulistan BahatMariana AlvesMariana AlvesMariana AlvesMario BoM. Cristina PolidoriNicola VeroneseAlberto Pilottosubject
medicine.medical_specialtyAtrial fbrillation · Advanced age · Older patients · Anticoagulation · Cognitive impairmentClinical Decision-MakingCardiologyManagement of atrial fibrillationReviewPalpationAnticoagulationOlder patientsOlder patientsHumansMedicineIntensive care medicineGeriatric AssessmentContraindicationAgedFrailtymedicine.diagnostic_testbusiness.industryPerspective (graphical)Atrial fibrillationAdvanced agemedicine.diseaseAtrial fibrillationClinical trialCognitive impairmentAdvanced age; Anticoagulation; Atrial fibrillation; Cognitive impairment; Older patientsCardiothoracic surgerybusinessdescription
Key Summary Points Aim To provide a geriatric perspective on the 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio–Thoracic Surgery (EACTS). Findings While the large majority of AF patients in real life are older, frail and cognitively impaired, these are mostly excluded from clinical trials, and physicians’ attitudes often prevail over standardized algorithms. On the basis of existing evidence, we suggest that (1) opportunistic AF screening by pulse palpation or ECG rhythm strip is cost-effective, and (2) whereas advanced chronological age by itself is not a contraindication to AF treatment, a Comprehesive Geriatric Assessment (CGA) including frailty, cognitive impairment, falls and bleeding risk may assist in clinical decision making to provide the best individualized treatment. Message The integration of CGA might positively influence clinical decision making in older patients with atrial fibrillation.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 |